• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Characterization of the murine myeloid precursor cell line MuMac-E8
 
  • Details
  • Full
Options
2014
Journal Article
Title

Characterization of the murine myeloid precursor cell line MuMac-E8

Abstract
Starting point for the present work was the assumption that the cell line MuMac-E8 represents a murine cell population with stem cell properties. Preliminary studies already pointed to the expression of stem-cell associated markers and a self-regenerative potential of the cells. The cell line MuMac-E8 should be examined for their differential stage within stem cell hierarchy. MuMac-E8 cells were derived from a chimeric mouse model of arthritis. It could be shown that MuMac-E8 cells express mRNA of some genes associated with pluripotent stem cells (Nanog, Nucleostemin), of genes for hematopoietic markers (EPCR, Sca-1, CD11b, CD45), for the mesenchymal marker CD105 and of genes for the neural markers Pax-6 and Ezrin. In methylcellulose and May-Grünwald-Giemsa staining, hematopoietic colonies were obtained but the hematopoietic system of lethally irradiated mice could not be rescued. Osteogenic differentiation was not detectable. Thus, it became evident that MuMac-E8 represents not a stem cell line. However, MuMac-E8 cells expressed several myeloid surface markers (i.e. CD11b, F4/80, CD14, CD64), showed phagocytosis and is capable of producing nitric oxide. Thus, this cell line seems to be arrested an advanced stage of myeloid differentiation. Adherence data measured by impedance-based real-time cell analysis together with cell morphology data suggested that MuMac-E8 represents a new macrophage precursor cell line exhibiting weak adherence. This cell line is suitable as an in-vitro model for testing of macrophage functions. Moreover, it might be also useful for differentiation or reprogramming studies.
Author(s)
Fricke, Stephan  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Pfefferkorn, Cathleen
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Wolf, Doris
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Riemschneider, Sina  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Kohlschmidt, Janine
Hilger, Nadja  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Füldner, Christiane
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Knauer, Jens  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Sack, Ulrich
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Emmrich, Frank
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Lehmann, Jörg  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Journal
PLoS one. Online journal  
Open Access
DOI
10.1371/journal.pone.0113743
Additional link
Full text
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024